newsfilter
← Latest News
GlobeNewswire·

INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

  • INVO Fertility, Inc. entered a securities purchase agreement with a single institutional investor to sell 2,366,864 shares or pre-funded warrants plus warrants for up to 4,733,728 additional shares.
  • The private placement is priced at $1.69 per combined unit under Nasdaq rules, with warrants exercisable at $1.69 per share upon shareholder approval and expiring five years later.
  • Gross proceeds are estimated at approximately $4.0 million before fees, with the offering expected to close on or about December 3, 2025.
  • Maxim Group LLC is acting as the sole placement agent for the transaction.
  • The securities were sold under Section 4(a)(2) of the Securities Act of 1933, are unregistered, and will be registered for resale via an SEC filing.
  • INVO Fertility operates two INVO Centers, one IVF clinic, and distributes its INVOcell intravaginal culture technology to third-party clinics.